Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlevoLogic LLC, operating under the commercial brand Propel Orthodontics, is a medical technology company that develops innovative solutions to accelerate orthodontic treatment. The company's flagship technology, the Propel system, utilizes alveolar micro-perforation to stimulate bone remodeling and significantly increase the rate of tooth movement. This clinical procedure is used in conjunction with traditional braces or clear aligners to reduce overall treatment time and improve clinical outcomes for patients. In June 2021, the assets of Propel Orthodontics, including its Propel and VPro product lines, were acquired by Dentsply Sirona for approximately $131 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlevoLogic.